GeminIQ Website Logo

Viewing CBDY free

Subscribe for full history, 90+ metrics, screener, watchlist...

Target Group Inc.

CBDY

Companies in Medicinal Chemicals & Botanical Products

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash
000112121101
Restricted Cash
000000000000
Accounts Receivable Net Current
000010000100
Inventory Net
221121111121
Prepaid Expense Current
000000000000
Financing Receivable Excluding Accrued Interest Af…
---0000-----
Interest Receivable Current
---0000-----
Value Added Tax Receivable Current
000000000-00
Other Receivables
--0000000000
Other Assets Current
00---0---0--
Assets Current
222223332333
Assets Noncurrent
Property Plant And Equipment Net
344444555556
Goodwill
000000000000
Operating Lease Right Of Use Asset
000000000000
Assets Noncurrent
444444555666
Assets
666778887989
Liabilities And Stockhold…
Liabilities
Bank Overdrafts
000000000000
Accounts Payable And Accrued Liabilities Current
332223332333
Deferred Revenue Current
000---0000--
Operating Lease Liability Current
000000000000
Sales And Excise Tax Payable Current
-0---0---0--
Convertible Notes Payable Current
000000000000
Derivative Liabilities Current
000000000000
Liabilities Current
1413131012131313131588
Liabilities Noncurrent
Accounts Payable Interest Bearing Noncurrent
---3------66
Operating Lease Liability Noncurrent
111111111111
Derivative Liabilities Noncurrent
---000000000
Liabilities Noncurrent
111411111178
Liabilities
151414141314151414161516
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital
252525252525252525252525
Retained Earnings Accumulated Deficit
-33-32-32-31-31-31-31-31-31-31-31-31
Accumulated Other Comprehensive Income Loss Net Of…
-1-1-1-1-1-1-1-1-1-1-1-1
Stockholders Equity
-9-8-7-7-7-7-7-6-7-7-7-7
Liabilities And Stockholders Equity
666778887989

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-16.67%-33.33%-33.33%---------
202511.76%35.29%-35.29%0.00%0.00%64.71%-4.55%-36.36%-31.82%-11.11%-11.11%-16.67%
2024-13.33%3.33%-26.67%30.00%5.00%35.00%-16.67%-41.67%-58.33%-9.09%-22.73%-9.09%
2023---1.72%29.31%-41.38%69.57%-21.74%4.35%44.74%-21.05%-28.95%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.18
0.17
0.17
0.23
0.20
0.24
0.19
0.21
0.13
0.21
0.31
0.36
Quick Ratio
0.06
0.05
0.06
0.13
0.06
0.17
0.12
0.14
0.06
0.13
0.08
0.21
Working Capital
-11.34M
-11.05M
-10.56M
-7.66M
-9.93M
-9.99M
-10.90M
-10.40M
-11.29M
-11.50M
-5.83M
-5.10M
Leverage & Debt
Debt to Equity
-1.71
-1.77
-1.83
-1.94
-2.01
-2.16
-2.08
-2.24
-2.00
-2.27
-2.21
-2.37
Interest Coverage TTM
-0.67
-0.30
0.43
0.39
1.23
1.14
0.81
0.95
1.16
0.77
-2.00
-2.11
Debt Ratio
2.41
2.31
2.20
2.07
1.99
1.86
1.92
1.81
2.00
1.79
1.82
1.73
Efficiency & Turnover
Asset Turnover TTM
0.53
0.56
0.95
0.77
0.88
0.80
0.40
0.62
0.76
0.45
0.11
0.07
Days Sales Outstanding TTM
59.76
24.61
10.00
25.74
22.07
30.69
9.90
16.55
2.94
50.71
22.73
0.99
Receivables Turnover TTM
6.11
14.83
36.51
14.18
16.54
11.89
36.85
22.05
124.28
7.20
16.06
367.01
Per Share Metrics
Diluted EPS TTM
-0.00
-0.00
-0.00
-0.00
0.00
0.00
-0.00
-0.00
0.00
-0.00
-0.01
-0.01
Free Cash Flow Per Share TTM
-0.00
-0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.00
-0.00
0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
44.31%
53.28%
43.64%
53.26%
60.70%
56.51%
89.33%
59.12%
35.76%
44.49%
-
-
Operating Profit Margin TTM
-53.63%
-35.03%
-9.03%
-11.52%
4.04%
2.43%
-7.48%
-1.30%
4.06%
-8.70%
-388.11%
-525.68%
Net Profit Margin TTM
-53.63%
-35.03%
-9.03%
-11.52%
4.04%
2.43%
-7.48%
-1.30%
4.06%
-8.70%
-388.11%
-525.68%
Growth Metrics
Net Revenue Growth (1Y)
-44.67%
-41.12%
103.73%
6.23%
7.66%
77.19%
207.30%
589.90%
-511.72%
-
-
-
Net Income Growth (1Y)
-834.06%
-947.13%
145.99%
838.73%
7.25%
-149.59%
-94.08%
-98.29%
-104.86%
-92.84%
516.27%
-318.73%
EPS Growth (1Y)
-834.06%
-947.13%
145.99%
838.73%
7.25%
-149.59%
-94.08%
-98.29%
-104.86%
-92.84%
516.27%
-318.73%
Valuation Metrics
P/E TTM
-0.62
-0.68
-1.77
-2.21
5.78
5.38
-5.39
-28.01
8.90
-3.43
-1.14
-0.93
P/B TTM
-0.13
-0.11
-0.14
-0.20
-0.21
-0.13
-0.19
-0.30
-0.29
-0.16
-0.68
-0.56
P/S TTM
0.33
0.24
0.16
0.26
0.23
0.13
0.40
0.37
0.36
0.30
4.42
4.88
Market Cap
1.11M
925.54K
1.05M
1.42M
1.42M
863.84K
1.30M
1.91M
2.04M
1.11M
4.63M
3.70M
Enterprise Value
901.23K
817.22K
703.68K
573.71K
637.94K
-1.01M
3.23K
171.14K
1.28M
366.11K
4.17M
2.65M
Calculated Values
Free Cash Flow TTM
-366.09K
-842.43K
144.80K
321.59K
818.23K
2.16M
1.72M
688.98K
371.60K
-589.61K
-823.90K
661.28K
Net Debt
-209.42K
-108.32K
-345.27K
-845.45K
-781.22K
-1.88M
-1.29M
-1.74M
-753.59K
-744.54K
-453.44K
-1.06M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2019-03-18Sale
Owner: Starr, Sasha
Title: President/Director
Shares: 19,500
Price/Share: $0.10
Value: $1,950.00
Shares Owned: 9,219,206
Relationship: Director,Officer
Ownership: Direct
2019-03-15Sale
Owner: Schindermann, Rubin
Title: CEO/Director
Shares: 13,000
Price/Share: $0.12
Value: $1,560.00
Shares Owned: 9,075,706
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
51.03%
Inst. Shares: 314,872,495
Shares Outstanding: 617,025,999
2025-12-31
59.68%
Inst. Shares: 368,262,969
Shares Outstanding: 617,025,999
2025-09-30
58.53%
Inst. Shares: 361,139,136
Shares Outstanding: 617,025,999
2025-06-30
59.39%
Inst. Shares: 366,454,266
Shares Outstanding: 617,025,999
2025-03-31
58.58%
Inst. Shares: 361,468,821
Shares Outstanding: 617,025,999

Target Group Inc. (CBDY) — SEC Financial Statements & Analysis

Target Group Inc. (CBDY) is a medicinal chemicals & botanical products company, incorporated in DE. Target Group Inc. trades on OTC as: CBDY. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Target Group Inc. reported a -44.67% year-over-year revenue growth, a Gross Profit Margin of 44.31% (TTM), a Debt-to-Equity ratio of -1.71x, a Price-to-Sales (P/S) ratio of 0.33x (TTM), a Price-to-Book (P/B) ratio of -0.13 (TTM), at a market cap of $1.11M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-44.67%
Gross Profit Margin TTM
44.31%
Debt To Equity
-1.71x
P/S TTM
0.33x
P/B TTM
-0.13
Market Cap
$1.11M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Target Group Inc. in?

Target Group Inc. (CBDY) operates in the Medicinal Chemicals & Botanical Products industry.

What is CBDY's market cap?

Target Group Inc. (CBDY) has a market capitalization of $1.11M as of 2026-03-31.

What exchange does CBDY trade on?

Target Group Inc. (CBDY) trades on the OTC.

Where is Target Group Inc. incorporated?

Target Group Inc. is incorporated in DE.

Research Faster.
Invest Smarter.

Target Group Inc. (CBDY) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.